摘要 |
The invention relates to bis 1, 8 naphthalimide compounds including antibody drag conjugate (ADC) compounds represented by Formula (I) : where one or more 1, 8 bis-naphthalimide drug moieties (D) having Formulas (IIa) and (IIb) are covalently linked, through the wavy line, by a linker (L) to an antibody (Ab). The invention also relates to heterocyclic-substituted 1, 8 bis-naphthalimide compounds having Formula (XV). The invention also relates to pharmaceutical compositions comprising an effective amount of a Formula (I) ADC or Formula (XV) heterocyclic-substituted 1, 8 bis-naphthalimide compound for treatment of hyperproliferative disorders and other disorders. The invention also relates to methods for killing or inhibiting the proliferation of tumor cells or cancer cells including administering to a patient an effective amount of a Formula (I) ADC or Formula (XV) compound. |
申请人 |
GENENTECH, INC.;GAZZARD, LEWIS, J.;HA, EDWARD, HYUNGSUK;JACKSON, DAVID, Y.;UM, JOANN |
发明人 |
GAZZARD, LEWIS, J.;HA, EDWARD, HYUNGSUK;JACKSON, DAVID, Y.;UM, JOANN |